https://www.selleckchem.com/products/AZD0530.html
570-9.98, being on anastrozole (OR=0.139, 95%CI 0.040-0.485), getting a thorough therapeutic communication about treatment (OR=4.590, 95%CI 1.061-19.863), undergoing mastectomy (OR=0.215, 95%CI 0.059-0.788), having side effects (OR=0.210, 95%CI 0.085-0.517) were found to be significantly associated with adherence to AHT. In general, the overall adherence to AHT was 77.5% for women with breast cancer. Factors such as types of adjuvant hormone therapy, lack of side effects, mastectomy, getting social support, and thorough therapeutic co